| scholarly article | Q13442814 |
| P50 | author | Mark D. Gorrell | Q38799589 |
| Matthew B O'Rourke | Q57015705 | ||
| Hui Zhang | Q59693890 | ||
| Oliver Schilling | Q61159147 | ||
| P2093 | author name string | Geoffrey W McCaughan | |
| Stephen M Twigg | |||
| Angelina J Lay | |||
| Stefan Tholen | |||
| Martin L Biniossek | |||
| Ben Roediger | |||
| Fiona M Keane | |||
| Maria Magdalena Koczorowska | |||
| Charles G Bailey | |||
| Elizabeth J Hamson | |||
| Quintin Lee | |||
| Sumaiya Chowdhury | |||
| P2860 | cites work | Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms | Q22009107 |
| Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts | Q22010913 | ||
| Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α | Q24292941 | ||
| Mouse fibroblast-activation protein--conserved Fap gene organization and biochemical function as a serine protease | Q24319913 | ||
| Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9 | Q26995871 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| The application of the fibroblast activation protein α-targeted immunotherapy strategy | Q28073437 | ||
| Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders | Q28116286 | ||
| Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase | Q28147264 | ||
| A statistical model for identifying proteins by tandem mass spectrometry | Q28186251 | ||
| Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton | Q28206963 | ||
| Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search | Q28211385 | ||
| Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha | Q28243456 | ||
| A common open representation of mass spectrometry data and its application to proteomics research | Q28291914 | ||
| Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry | Q28360826 | ||
| A family of Acrp30/adiponectin structural and functional paralogs | Q28513966 | ||
| Network analyses reveal pervasive functional regulation between proteases in the human protease web | Q28539127 | ||
| Human FGF-21 Is a Substrate of Fibroblast Activation Protein | Q28550659 | ||
| A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake | Q28587213 | ||
| The International Protein Index: an integrated database for proteomics experiments | Q29614533 | ||
| ProteomeXchange provides globally coordinated proteomics data submission and dissemination | Q29614806 | ||
| TANDEM: matching proteins with tandem mass spectra | Q29615238 | ||
| Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics | Q29615818 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. | Q30596736 | ||
| Assessment and improvement of statistical tools for comparative proteomics analysis of sparse data sets with few experimental replicates | Q30656644 | ||
| FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells | Q31018027 | ||
| Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity | Q33231553 | ||
| Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites | Q33337380 | ||
| ProteoWizard: open source software for rapid proteomics tools development | Q33349681 | ||
| MS-viewer: a web-based spectral viewer for proteomics results | Q33583211 | ||
| Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform | Q33742666 | ||
| Targeted disruption of mouse fibroblast activation protein | Q33961797 | ||
| Factor Xa subsite mapping by proteome-derived peptide libraries improved using WebPICS, a resource for proteomic identification of cleavage sites | Q33993989 | ||
| Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues | Q34059219 | ||
| Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products | Q34102556 | ||
| Identifying and quantifying proteolytic events and the natural N terminome by terminal amine isotopic labeling of substrates | Q34220314 | ||
| A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion | Q34293695 | ||
| Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality | Q35040181 | ||
| Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells. | Q35116175 | ||
| Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis | Q35691528 | ||
| Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases | Q35696305 | ||
| CCN1 induces hepatic ductular reaction through integrin αvβ₅-mediated activation of NF-κB. | Q35720021 | ||
| Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations | Q35754294 | ||
| Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV. | Q35762194 | ||
| CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis | Q36139328 | ||
| Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells | Q36534480 | ||
| Circulating FGF21 proteolytic processing mediated by fibroblast activation protein | Q36611366 | ||
| Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21 | Q36674741 | ||
| Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice | Q36778823 | ||
| Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. | Q36865097 | ||
| Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture | Q37141388 | ||
| Monocyte chemoattractant protein-1 (MCP-1): an overview | Q37481208 | ||
| Metabolic function of the CTRP family of hormones. | Q37597694 | ||
| Functional genomic screen identifies novel mediators of collagen uptake | Q37607531 | ||
| The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo | Q37727031 | ||
| The rationale for targeting the LOX family in cancer | Q38027412 | ||
| Proteomic identification of protease cleavage sites: cell-biological and biomedical applications | Q38151761 | ||
| Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. | Q38182507 | ||
| Dipeptidyl peptidase 9 substrates and their discovery: current progress and the application of mass spectrometry-based approaches. | Q38842469 | ||
| The stromal cell-surface protease fibroblast activation protein-α localizes to lipid rafts and is recruited to invadopodia. | Q38849429 | ||
| The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. | Q38869147 | ||
| Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin. | Q38930954 | ||
| Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells | Q39080408 | ||
| Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism | Q39177343 | ||
| Properties of 7ND-CCL2 are modulated upon fusion to Fc. | Q39385980 | ||
| Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts | Q39463052 | ||
| A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling | Q39534167 | ||
| Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug | Q39599536 | ||
| C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages | Q39676967 | ||
| Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. | Q39735458 | ||
| Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line | Q40370679 | ||
| FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling | Q40740027 | ||
| Fibroblast activation protein (FAP) as a novel metabolic target | Q41166927 | ||
| Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. | Q41449567 | ||
| Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome. | Q41462476 | ||
| Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin | Q43090748 | ||
| Neuropeptide Y is a physiological substrate of fibroblast activation protein: Enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma | Q46631582 | ||
| Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein | Q46751819 | ||
| Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma | Q47696181 | ||
| Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis | Q47890838 | ||
| Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase? | Q47922336 | ||
| NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency. | Q52173082 | ||
| Regulation of fibrinolysis by S100A10 in vivo. | Q53232100 | ||
| Expression of a secretory protein C1qTNF6, a C1qTNF family member, in hepatocellular carcinoma. | Q53287746 | ||
| Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes. | Q55442577 | ||
| DBToolkit: processing protein databases for peptide-centric proteomics | Q58034927 | ||
| A rare variant in human fibroblast activation protein associated with ER stress, loss of enzymatic function and loss of cell surface localisation | Q87646195 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 1 | |
| P304 | page(s) | 65-85 | |
| P577 | publication date | 2018-09-26 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Identification of Novel Natural Substrates of Fibroblast Activation Protein-alpha by Differential Degradomics and Proteomics | |
| P478 | volume | 18 |
| Q100316387 | AND-gate contrast agents for enhanced fluorescence-guided surgery |
| Q100751371 | Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy |
Search more.